Intelligent Ops Fund

www.intelligencevc.com

VCMatch tracks Intelligent Ops Fund as an investor focused on AI/ML, Biotech, and Medtech companies, Pre-Seed and Seed rounds, United States and Canada markets, and $50k to $25m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$50k to $25m

Stages

Pre-Seed, Seed

Focus Areas

AI/ML, Biotech, Medtech

Geography

United States and Canada

Investment Thesis

Intelligence Ventures is a research-first, domain-specialist seed fund that believes durable value in AI healthcare is created by proprietary datasets that compound into defensible moats. They invest early (pre-seed and seed), move quickly with small initial checks, and back companies only when AI is core to the product—favoring startups where removing the AI would break the product. The team combines deep landscape research, scientific rigor, and operational domain expertise to source, diligenc e, and support founders in a focused set of healthcare verticals.

Is Intelligent Ops Fund right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Intelligent Ops Fund is most relevant for founders raising Pre-Seed and Seed rounds in AI/ML, Biotech, Medtech, and Pharma, especially across United States and Canada, with public check-size signals around $50k to $25m.

Focus statement

They back pre-seed and seed AI-powered healthcare startups in the United States and Canada that own or generate proprietary datasets; their stated mantra is: "in AI healthcare, the data is the product."

Value Add

Research-first sourcing and published proprietary research (60+ page "State of AI Healthcare") built from their actual pipeline
Pipeline growth of 20–30 new companies every week and a proprietary dataset used to identify white space and overcrowded sub-niches
Scientific rigor with "scientists in the room on every diligence" and a four-filter investment screen (proprietary data, sound science, multi-disciplinary team, credible path to category-defining outcome)
Small, concentrated emerging-manager fund structure that targets opportunities larger funds miss and reserves pro-rata for top performers
Fast, founder-friendly execution with rapid decisions and initial checks of $25K–$50K (they explicitly say "We back founders with fast $50K checks")
Strict operational and geographic requirements: companies must already be operational and based in the US or Canada
Clear exclusion set: do not invest in therapeutics and will not back companies where AI is only a wrapper or workflow enhancement